REMINDER: This podcast should not be considered medical advice. Please speak to your doctor to determine whether Afrezza is right for you.

I am thrilled to release this episode with Michael Castagna PharmD, CEO of MannKind. MannKind is the maker of Afrezza, the inhaled insulin. Listen back to Episode 25 released on May 18, 2022 (link below) if you want my initial impressions of Afrezza. As you may have gathered from listening to this podcast, I'm a huge fan of Afrezza. It has completely changed how I manage my diabetes and it has greatly simplified my daily routine. Afrezza is a game changer for people that take insulin (both Type 1 and Type 2 diabetics).

Michael provides tons of useful information about what Afrezza is, how dosing works, who Afrezza is appropriate for, how to get a prescription, how to pay for it, etc. We go in-depth on some really important topics and I think you will find this episode to be extremely useful.

If you are interested in Afrezza, please reach out to Afrezza Assist to get the process started. They are extremely helpful and will let you know what to expect as you speak to your doctor, insurance company, and pharmacy. https://afrezzaassist.com

Episode Links:

Episode 25 - my initial thoughts on Afrezza https://stream.redcircle.com/episodes/a48ce257-6477-4472-a7b2-3ecebeab6c00/stream.mp3

Afrezza FAQs: https://afrezza.com/faqs/

Prescribing doctors: https://afrezza.com/find-a-doctor/

Afrezza Assist: https://afrezzaassist.com